Effectiveness and safety of upadacitinib for moderate‐to‐severe atopic dermatitis in a real‐world setting: A 52‐week retrospective study
Gargiulo, L., Ibba, L., Piscazzi, F., Alfano, A., Cascio Ingurgio, R., Valenti, M., Costanzo, A., Narcisi, A.
Published in Journal of the European Academy of Dermatology and Venereology (01.02.2024)
Published in Journal of the European Academy of Dermatology and Venereology (01.02.2024)
Get full text
Journal Article
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study
Gargiulo, L, Ibba, L, Piscazzi, F, Amoruso, F, Balato, A, Barei, F, Bertello, M, Burroni, A G, Caccavale, S, Ferrucci, S M, Foti, C, Gaiani, F M, Girolomoni, G, Malagoli, P, Marzano, A V, Maurelli, M, Napolitano, M, Nettis, E, Ortoncelli, M, Patruno, C, Pezzolo, E, Ribero, S, Romita, P, Rossi, M T, Zaza, I, Costanzo, A, Narcisi, A
Published in Journal of the European Academy of Dermatology and Venereology (01.09.2024)
Published in Journal of the European Academy of Dermatology and Venereology (01.09.2024)
Get full text
Journal Article